variant ii haemoglobin a1c analyser (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
90
Structured Review
Bio-Rad
variant ii haemoglobin a1c analyser
Variant Ii Haemoglobin A1c Analyser, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/variant+ii+haemoglobin+a1c+analyser/variant+ii+haemoglobin+a1c+analyser/pm38130181-72-12-17
Average 90 stars, based on 1 article reviews
Variant Ii Haemoglobin A1c Analyser, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/variant+ii+haemoglobin+a1c+analyser/variant+ii+haemoglobin+a1c+analyser/pm38130181-72-12-17
Average 90 stars, based on 1 article reviews
variant ii haemoglobin a1c analyser - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Liquid Chromatography:Article Title: Insulin resistance is associated with the presence and severity of retinopathy in patients with type 2 diabetes. Article Snippet: Funding information Health Commission of Heilongjiang Province, Grant/Award Number: 20230303060221 Abstract Background: To assess the relationship between novel insulin resistance (IR) indices and the presence and severity of diabetic retinopathy (DR) in patients with type 2 diabetes.. Methods: This is a cross-sectional study involving 2211 patients.. The study outcomes were DR events. Variant Assay:Article Title: Insulin resistance is associated with the presence and severity of retinopathy in patients with type 2 diabetes. Article Snippet: Funding information Health Commission of Heilongjiang Province, Grant/Award Number: 20230303060221 Abstract Background: To assess the relationship between novel insulin resistance (IR) indices and the presence and severity of diabetic retinopathy (DR) in patients with type 2 diabetes.. Methods: This is a cross-sectional study involving 2211 patients.. The study outcomes were DR events. |